Evaluating the effectiveness of the 4CMenB vaccine against invasive meningococcal disease and gonorrhoea in an infant, child and adolescent program: protocol

Invasive meningococcal disease causes significant morbidity and mortality worldwide, with serogroup B being one of the predominant serogroups in Australia for many years. The South Australian (SA) State Government recently funded the introduction of a 4CMenB vaccination program for infants, children...

Descripción completa

Detalles Bibliográficos
Autores principales: Marshall, Helen S., Andraweera, Prabha H., Wang, Bing, McMillan, Mark, Koehler, Ann P., Lally, Noel, Almond, Sara, Denehy, Emma, A’Houre, Michele, Giles, Lynne C., Flood, Louise
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078704/
https://www.ncbi.nlm.nih.gov/pubmed/33428528
http://dx.doi.org/10.1080/21645515.2020.1827614

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078704/
https://www.ncbi.nlm.nih.gov/pubmed/33428528
http://dx.doi.org/10.1080/21645515.2020.1827614

Ejemplares similares